Jonas Siddhartha Waizenegger

Dr. Jonas Siddhartha Waizenegger is an Assistant Professor at the University of Hamburg's Faculty of Medicine, affiliated with the II. Medical Clinic and Polyclinic and the Center for Oncology. His research focuses on hematologic malignancies, particularly acute myeloid leukemia (AML), myeloproliferative neoplasms, and multiple myeloma. He investigates therapeutic targets like AXL kinase inhibition and drug combinations for refractory cases, with a clinical emphasis on improving treatment efficacy and patient outcomes. His work spans molecular mechanisms, drug development, and translational research. Notably, he contributed to trials involving Bemcentinib and venetoclax-based regimens. Dr. Waizenegger collaborates on clinical trials and molecular studies, aiming to advance targeted therapies in oncology. He is fluent in German and English.